Growth Metrics

BioNTech SE (BNTX) Gross Profit (2019 - 2025)

BioNTech SE's Gross Profit history spans 8 years, with the latest figure at -$344.8 million for Q4 2025.

  • On a quarterly basis, Gross Profit fell 100.01% to -$344.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.1 billion, a 99.97% decrease, with the full-year FY2025 number at $2.5 billion, up 641.18% from a year prior.
  • Gross Profit hit -$344.8 million in Q4 2025 for BioNTech SE, down from $1.6 billion in the prior quarter.
  • Over the last five years, Gross Profit for BNTX hit a ceiling of $3526.1 billion in Q4 2024 and a floor of -$344.8 million in Q4 2025.
  • Historically, Gross Profit has averaged $178.2 billion across 5 years, with a median of $1.5 billion in 2023.
  • Biggest five-year swings in Gross Profit: surged 252014.16% in 2024 and later plummeted 204.66% in 2025.
  • Tracing BNTX's Gross Profit over 5 years: stood at $5.7 billion in 2021, then dropped by 26.21% to $4.2 billion in 2022, then plummeted by 66.52% to $1.4 billion in 2023, then surged by 252014.16% to $3526.1 billion in 2024, then crashed by 100.01% to -$344.8 million in 2025.
  • Business Quant data shows Gross Profit for BNTX at -$344.8 million in Q4 2025, $1.6 billion in Q3 2025, and -$77.7 million in Q2 2025.